Cargando…
Statistical analysis plan for stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) study
Antidepressant medications are commonly used to treat depression, but only about 30% of patients reach remission with any single first-step antidepressant. If the first-step treatment fails, response and remission rates at subsequent steps are even more limited. The literature on biomarkers for trea...
Autores principales: | Petkova, Eva, Ogden, R. Todd, Tarpey, Thaddeus, Ciarleglio, Adam, Jiang, Bei, Su, Zhe, Carmody, Thomas, Adams, Philip, Kraemer, Helena C., Grannemann, Bruce D., Oquendo, Maria A., Parsey, Ramin, Weissman, Myrna, McGrath, Patrick J., Fava, Maurizio, Trivedi, Madhukar H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485858/ https://www.ncbi.nlm.nih.gov/pubmed/28670629 http://dx.doi.org/10.1016/j.conctc.2017.02.007 |
Ejemplares similares
-
Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial
por: Cooper, Crystal M., et al.
Publicado: (2019) -
Accounting for Dynamic Fluctuations across Time when Examining fMRI Test-Retest Reliability: Analysis of a Reward Paradigm in the EMBARC Study
por: Chase, Henry W., et al.
Publicado: (2015) -
Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial
por: Giles, Michael A., et al.
Publicado: (2023) -
Brain Ventricle and Choroid Plexus Morphology as Predictor of Treatment Response: Findings from the EMBARC Study
por: Murck, Harald, et al.
Publicado: (2023) -
Optimising treatment decision rules through generated effect modifiers: a precision medicine tutorial
por: Petkova, Eva, et al.
Publicado: (2019)